BioCentury | May 13, 2020
Product Development

Gilead secures global access to remdesivir via generic manufacturing deals

...Médicale (INSERM) will receive a grant to test repurposed and novel agents in the clinic. Exvastat Ltd....
Items per page:
1 - 1 of 1
BioCentury | May 13, 2020
Product Development

Gilead secures global access to remdesivir via generic manufacturing deals

...Médicale (INSERM) will receive a grant to test repurposed and novel agents in the clinic. Exvastat Ltd....
Items per page:
1 - 1 of 1